Literature DB >> 7114816

Kuru with incubation periods exceeding two decades.

S B Prusiner, C Gajdusek, M P Alpers.   

Abstract

The clinical characteristics of kuru in 15 patients are described. All the patients had a history of joint pains preceding difficulty walking. The severity of the neurological dysfunction varied from mild truncal and limb ataxia necessitating the use of a stick for walking to terminal illness accompanied by marked ataxia, rigidity, spasticity, and dementia. All the patients with kuru in this study had a apprehensive, frightened facial expression. Most of the patients examined showed diminished or absent optokinetic nystagmus bilaterally. Apprehensive facies and diminished optokinetic nystagmus have not previously been described in kuru. The other clinical features of the current patients with kuru are similar to those recorded twenty years ago. Epidemiological surveillance, anamnesis, and missionary reports strongly suggest that all the patients described in this study were exposed to the kuru agent more than two decades ago through ritualistic cannibalism. Thus the incubation period or time interval from exposure to the onset of clinical illness exceeds two decades, while the duration of illness is two years or less. The cause of these extraordinarily long incubation periods is unknown but may result in part from exposure to small doses of the kuru agent through an inefficient oral route.

Entities:  

Mesh:

Year:  1982        PMID: 7114816     DOI: 10.1002/ana.410120102

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  Kuru: genes, cannibals and neuropathology.

Authors:  Pawel P Liberski; Beata Sikorska; Shirley Lindenbaum; Lev G Goldfarb; Catriona McLean; Johannes A Hainfellner; Paul Brown
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

2.  Mortality from dementia in occupations at risk of exposure to bovine spongiform encephalopathy: analysis of death registrations.

Authors:  P Aylin; J Bunting; B De Stavola; M P Coleman
Journal:  BMJ       Date:  1999-04-17

Review 3.  Etiology and pathogenesis of prion diseases.

Authors:  S J DeArmond; S B Prusiner
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

4.  Experiments on maternal and paternal transmission of Creutzfeldt-Jakob disease in mice.

Authors:  F Taguchi; Y Tamai; S Miura
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  The cellular concentration of the yeast Ure2p prion protein affects its propagation as a prion.

Authors:  Myriam Crapeau; Christelle Marchal; Christophe Cullin; Laurent Maillet
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

6.  Huntington's disease and leprosy in a New Guinea Highlander.

Authors:  E M Scrimgeour
Journal:  J Med Genet       Date:  1983-12       Impact factor: 6.318

7.  A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome.

Authors:  K J Lui; D N Lawrence; W M Morgan; T A Peterman; H W Haverkos; D J Bregman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Protein aggregation and the evolution of stress resistance in clinical yeast.

Authors:  Yiwen R Chen; Inbal Ziv; Kavya Swaminathan; Joshua E Elias; Daniel F Jarosz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-04-19       Impact factor: 6.671

9.  Some tributes to research colleagues and other contributors to our knowledge about kuru.

Authors:  Michael P Alpers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

10.  Oral transmissibility of prion disease is enhanced by binding to soil particles.

Authors:  Christopher J Johnson; Joel A Pedersen; Rick J Chappell; Debbie McKenzie; Judd M Aiken
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.